VACCINE IMMUNOGENS
An immunogenic composition comprising: a) one or more plasmodium-derived ribosomal or ribosomal associated protein or immunogenic fragment thereof which has a sequence which is at least about 80%, 85%, 90%, 95%, 98%, 99% or 100% identical to a ribosomal or ribosomal associated protein or an immunogenic fragment of a ribosomal or ribosomal associated protein recited in Figure 1; or a ribosomal or ribosomal associated protein or peptide or immunogenic fragment thereof as recited in Figure 2 or Figure 3; and/or b) a polynucleotide encoding one or more protein, peptide or immunogenic fragment of a); wherein the immunogenic composition is for use in eliciting an immune response in a subject to treat or prevent malaria. Also provided are plasmodium-derived ETRAMPs and/or histones, or immunogenic fragments thereof, for use in eliciting an immune response in a subject, preferably to treat or prevent malaria..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Europäisches Patentamt - (2024) vom: 21. Feb. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
HILL ADRIAN VIVIAN SINTON [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-02-21, Last update posted on www.tib.eu: 2024-03-05, Last updated: 2024-03-08 |
---|
Patentnummer: |
EP4265271 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA018355110 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA018355110 | ||
003 | DE-627 | ||
005 | 20240308102114.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231103s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA018355110 | ||
035 | |a (EPA)EP4265271 | ||
035 | |a (EPA)67384615 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a HILL ADRIAN VIVIAN SINTON |e verfasserin |4 aut | |
245 | 1 | 0 | |a VACCINE IMMUNOGENS |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2024-02-21, Last update posted on www.tib.eu: 2024-03-05, Last updated: 2024-03-08 | ||
520 | |a An immunogenic composition comprising: a) one or more plasmodium-derived ribosomal or ribosomal associated protein or immunogenic fragment thereof which has a sequence which is at least about 80%, 85%, 90%, 95%, 98%, 99% or 100% identical to a ribosomal or ribosomal associated protein or an immunogenic fragment of a ribosomal or ribosomal associated protein recited in Figure 1; or a ribosomal or ribosomal associated protein or peptide or immunogenic fragment thereof as recited in Figure 2 or Figure 3; and/or b) a polynucleotide encoding one or more protein, peptide or immunogenic fragment of a); wherein the immunogenic composition is for use in eliciting an immune response in a subject to treat or prevent malaria. Also provided are plasmodium-derived ETRAMPs and/or histones, or immunogenic fragments thereof, for use in eliciting an immune response in a subject, preferably to treat or prevent malaria. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a BETTENCOURT PAULO JORGE GONCALVES DE |4 aut | |
700 | 0 | |a SPENCER ALEXANDRA JANE |4 aut | |
700 | 0 | |a TERNETTE NICOLA MARIA NATHALIE |4 aut | |
700 | 0 | |a SALMAN AHMED MAHMOUD AHMED AHMED |4 aut | |
700 | 0 | |a JUNQUEIRA CAROLINE FURTADO |4 aut | |
700 | 0 | |a GAZZINELLI RICARDO TOSTES |4 aut | |
700 | 0 | |a BARBOSA CAMILA RAQUEL RODRIGUES |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 21. Feb. |
773 | 1 | 8 | |g year:2024 |g day:21 |g month:02 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/67384615/publication/EP4265271A1?q=EP4265271 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2024 |b 21 |c 02 |